Skip to main content

CPHI Milan 2026

Meet us
in Milan.

DeepC is the AI co-scientist for pharmaceutical formulation. Bring a molecule or a reference product to stand 8S72 and watch it work, cited at the source.

Stand
8S72
Where
Hall 8, Start-up Market
Venue
Fiera Milano, Rho, Milan, Italy
Dates
6 to 8 October 2026
On stage
Tuesday 6 October, Hall 8, 8F56

Request a meeting.

Tell us which day suits you and what you are working on. We will confirm a time at the stand.

By submitting, you agree to our Privacy Policy.

info@deepceutix.comLondon, UKLinkedIn
Dr. Moe Elbadawi

On stage

How AI is Compressing Drug Development and Manufacturing Timelines

Dr. Moe Elbadawi, CEO & Co-Founder of DeepCeutix, joins the AI & Tech panel on how AI is shortening formulation and manufacturing timelines.

When
Tuesday 6 October
14:00 to 14:45, Milan time
Where
Hall 8, 8F56
Track
AI & Tech
CPHI conference agenda

At the stand

Bring a real problem.
Watch it run.

No slides. Each demo runs live on the molecule or product you name, and every number it returns links back to the regulatory record it came from.

01

Deformulation Agent

Name a reference product. DeepC reads the label for the Q1 baseline, holds every excipient to its IID ceiling, closes the mass balance, and returns a Q1/Q2 estimate with the dissolution target, the patent fences around it, and DMF holders for each ingredient.

You leave with: A deformulation report with per-excipient function and level estimates, a best-estimate Q1/Q2 composition, the dissolution target, patent constraints, and DMF sourcing options.

See the agent
02

FTO Agent

Bring a composition or an ANDA target. DeepC scores the patent risk, quotes the blocking claims line by line, and proposes design-arounds, with the Orange Book read for a Paragraph III or Paragraph IV route.

You leave with: An FTO map with claim-by-claim blocking analysis and three non-infringing alternatives.

See the agent
03

Nitrosamines Agent

Give it an API and its amine chemistry. DeepC derives the acceptable intake in ng/day under ICH M7(R2), assigns the CPCA category for a novel NDSRI, and drafts the control strategy.

You leave with: A nitrosamines risk assessment with CPCA category, AI in ng/day, and a control-strategy memo.

See the agent

Also at the stand: extractables and leachables under ICH Q3E, formulation design against IID precedent, and the biologics suite. See the full platform.

Find us

Hall 8.
Stand 8S72.

Zone
Start-up Market
Venue
Fiera Milano, Rho, Milan, Italy
6 and 7 October
10:00 to 18:30
8 October
10:00 to 16:00
Get a CPHI visitor passCPHI exhibitor list
DeepCeutix is exhibiting at CPHI Milan 2026, stand 8S72, 6 to 8 October 2026, Fiera Milano

Not travelling to Milan?

The same demo runs over a call. A formulation lead will be in touch within a business day.

Book a demo